Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6234352rdf:typepubmed:Citationlld:pubmed
pubmed-article:6234352lifeskim:mentionsumls-concept:C0085289lld:lifeskim
pubmed-article:6234352lifeskim:mentionsumls-concept:C1518997lld:lifeskim
pubmed-article:6234352lifeskim:mentionsumls-concept:C0524637lld:lifeskim
pubmed-article:6234352lifeskim:mentionsumls-concept:C0066563lld:lifeskim
pubmed-article:6234352lifeskim:mentionsumls-concept:C0024518lld:lifeskim
pubmed-article:6234352lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:6234352lifeskim:mentionsumls-concept:C0205160lld:lifeskim
pubmed-article:6234352lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:6234352lifeskim:mentionsumls-concept:C1417835lld:lifeskim
pubmed-article:6234352lifeskim:mentionsumls-concept:C1705928lld:lifeskim
pubmed-article:6234352lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:6234352lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:6234352lifeskim:mentionsumls-concept:C2347644lld:lifeskim
pubmed-article:6234352lifeskim:mentionsumls-concept:C1515655lld:lifeskim
pubmed-article:6234352lifeskim:mentionsumls-concept:C0591833lld:lifeskim
pubmed-article:6234352lifeskim:mentionsumls-concept:C0002131lld:lifeskim
pubmed-article:6234352pubmed:issue2lld:pubmed
pubmed-article:6234352pubmed:dateCreated1984-8-20lld:pubmed
pubmed-article:6234352pubmed:abstractTextSpecific mixed lymphocyte reaction (MLR) responsiveness to allogeneic major histocompatibility complex (MHC), or minor lymphocyte-stimulating (Mls) determinants, was depleted in the peripheral blood lymphocytes (PBL) obtained from mice 24 to 48 hr after i.v. injection of 5 to 7.5 X 10(7) MHC or Mlsa-incompatible spleen cells, respectively. Results of cell mixture experiments suggest that the generation of suppressor cells was not the explanation for this specific reduction in MLR proliferation occurring with these PBL responder cells. To gain additional insight into parameters involved in the recognition of allodeterminants in vivo, experimental manipulations of the host environment and donor cell inoculum utilized in the negative selection procedure were employed. For example, removal of the spleen in the recipient animal, an anatomic site in which injected allogeneic cells and corresponding host antigen-reactive cells (ARC) are trapped, still permitted the specific depletion in murine PBL of host ARC for donor foreign MHC antigens. This finding may implicate other sites such as the liver where unprimed host alloreactive clones are trapped. In addition, irradiation of allogeneic donor cells significantly reduced their capacity to trap alloreactive T cell clones in vivo, whereas heat treatment of the donor cells completely eliminated this ability, even though the Ia determinants were still expressed, measured by flow cytometry. After the negative selection period, kinetic analysis of proliferation showed that 3, 4, or 5 days after injection of MHC-incompatible allogeneic spleen cells, the PBL of the recipient showed specific hyperresponsiveness to the MHC-haplotype of the donor cells. Interestingly, these primed PBL responder cells had the volume distribution of small resting cells; thoracic duct lymphocytes (TDL), positively selected by adoptive transfer of T cells to irradiated semiallogeneic recipients, are reported to be mainly blast cells. In contrast to the MLR hyperresponsiveness that results from priming with MHC-incompatible splenocytes, PBL, obtained at these later time points from mice primed with Mlsa-incompatible, H-2-compatible splenocytes, showed complete unresponsiveness in MLR to these Mlsa-bearing stimulator cells, as well as some nonspecific reduction in proliferation to MHC-incompatible stimulator cells regardless of their Mls genotype.(ABSTRACT TRUNCATED AT 400 WORDS)lld:pubmed
pubmed-article:6234352pubmed:languageenglld:pubmed
pubmed-article:6234352pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6234352pubmed:citationSubsetAIMlld:pubmed
pubmed-article:6234352pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6234352pubmed:statusMEDLINElld:pubmed
pubmed-article:6234352pubmed:monthAuglld:pubmed
pubmed-article:6234352pubmed:issn0022-1767lld:pubmed
pubmed-article:6234352pubmed:authorpubmed-author:SellK WKWlld:pubmed
pubmed-article:6234352pubmed:authorpubmed-author:AhmedAAlld:pubmed
pubmed-article:6234352pubmed:authorpubmed-author:KindP DPDlld:pubmed
pubmed-article:6234352pubmed:authorpubmed-author:RyanJ JJJlld:pubmed
pubmed-article:6234352pubmed:authorpubmed-author:BerningA KAKlld:pubmed
pubmed-article:6234352pubmed:authorpubmed-author:ThompsonC BCBlld:pubmed
pubmed-article:6234352pubmed:issnTypePrintlld:pubmed
pubmed-article:6234352pubmed:volume133lld:pubmed
pubmed-article:6234352pubmed:ownerNLMlld:pubmed
pubmed-article:6234352pubmed:authorsCompleteYlld:pubmed
pubmed-article:6234352pubmed:pagination606-15lld:pubmed
pubmed-article:6234352pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:6234352pubmed:meshHeadingpubmed-meshheading:6234352-...lld:pubmed
pubmed-article:6234352pubmed:meshHeadingpubmed-meshheading:6234352-...lld:pubmed
pubmed-article:6234352pubmed:meshHeadingpubmed-meshheading:6234352-...lld:pubmed
pubmed-article:6234352pubmed:meshHeadingpubmed-meshheading:6234352-...lld:pubmed
pubmed-article:6234352pubmed:meshHeadingpubmed-meshheading:6234352-...lld:pubmed
pubmed-article:6234352pubmed:meshHeadingpubmed-meshheading:6234352-...lld:pubmed
pubmed-article:6234352pubmed:meshHeadingpubmed-meshheading:6234352-...lld:pubmed
pubmed-article:6234352pubmed:meshHeadingpubmed-meshheading:6234352-...lld:pubmed
pubmed-article:6234352pubmed:meshHeadingpubmed-meshheading:6234352-...lld:pubmed
pubmed-article:6234352pubmed:meshHeadingpubmed-meshheading:6234352-...lld:pubmed
pubmed-article:6234352pubmed:meshHeadingpubmed-meshheading:6234352-...lld:pubmed
pubmed-article:6234352pubmed:meshHeadingpubmed-meshheading:6234352-...lld:pubmed
pubmed-article:6234352pubmed:meshHeadingpubmed-meshheading:6234352-...lld:pubmed
pubmed-article:6234352pubmed:meshHeadingpubmed-meshheading:6234352-...lld:pubmed
pubmed-article:6234352pubmed:meshHeadingpubmed-meshheading:6234352-...lld:pubmed
pubmed-article:6234352pubmed:meshHeadingpubmed-meshheading:6234352-...lld:pubmed
pubmed-article:6234352pubmed:meshHeadingpubmed-meshheading:6234352-...lld:pubmed
pubmed-article:6234352pubmed:meshHeadingpubmed-meshheading:6234352-...lld:pubmed
pubmed-article:6234352pubmed:meshHeadingpubmed-meshheading:6234352-...lld:pubmed
pubmed-article:6234352pubmed:year1984lld:pubmed
pubmed-article:6234352pubmed:articleTitleRecognition and response to alloantigens in vivo. I. Negative and positive selection of MLR reactivity in murine peripheral blood lymphocytes to major histocompatibility complex and Mls antigens.lld:pubmed
pubmed-article:6234352pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6234352pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6234352lld:pubmed